Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:48 PM
Ignite Modification Date:
2025-12-24 @ 10:48 PM
NCT ID:
NCT02815969
Eligibility Criteria:
Inclusion criteria for all subjects:
* written informed consent
* age above 18 years
Inclusion criteria for patients with a NET: (one of these)
* histologically proven NET, with or without treatment for the NET
* a diagnosis made by a dedicated NET specialist based on a combination of physical symptoms and signs, imaging and laboratory values.
Inclusion criteria for healthy subjects:
\- Matching in age (plus or minus 3 years) and sex with one of the included NET patients.
Data of healthy subjects could also be used from the SERT-study, if the subject meets the criteria mentioned above.
Exclusion criteria for all subjects:
* Use of drugs or food supplements that interact with the serotonin-metabolism; all serotonin re-uptake inhibitors, psychotrophic drugs, (other antidepressants; tricyclic antidepressants, MAO-inhibitors, mirtazapin, bupropion, venlafaxin, duloxetin, anxiolytic, antipsychotic and anticonvulsive drugs).
* Drug abuse in the last 8 weeks.
* Use of ≥ 14 alcoholic consumptions a week for women.
* Use of ≥ 21 alcoholic consumptions a week for men.
Exclusion criteria for healthy subjects:
* Having a neuroendocrine tumor or neuroendocrine carcinoma from any grade and location in present or in history.
* Having a malignancy.
* Having an auto-immune disease.
* Having an infection.
* Having renal impairment.
* Use of interferon.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02815969
Study Brief:
Protocol Section:
NCT02815969